CH401 peptide is a HER2-derived antigen peptide. After CH401 peptide is bound to the artificial viral capsid by a self-assembled β-cyclic peptide and then encapsulated in a lipid bilayer containing the lipid adjuvant α-GalCer, it can be studied as a self-adjuvant anti-breast cancer vaccine candidate.

Physicochemical Properties

Molecular Formula	C114H173N29O32
Molecular Weight	2461.77
CAS #	503027-61-0
Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

References

[1]. Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate. J Am Chem Soc. 2023 Jul 26;145(29):15838-15847.

Solubility Data

Preparing Stock Solutions		1 mg	5 mg	10 mg
	1 mM	0.4062 mL	2.0311 mL	4.0621 mL
	5 mM	0.0812 mL	0.4062 mL	0.8124 mL
	10 mM	0.0406 mL	0.2031 mL	0.4062 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.